| Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study A Atti, F Insalata, EJ Carr, AD Otter, J Castillo-Olivares, M Wu, R Harvey, ... Journal of Infection 85 (5), 545-556, 2022 | 24 | 2022 |
| SARS-CoV-2 immunity and vaccine strategies in people with HIV C Mullender, KAS da Costa, A Alrubayyi, SL Pett, D Peppa Oxford open immunology 3 (1), iqac005, 2022 | 15 | 2022 |
| Exploiting pan influenza a and pan influenza B Pseudotype libraries for efficient vaccine antigen selection JMM Del Rosario, KAS Da Costa, B Asbach, F Ferrara, M Ferrari, ... Vaccines 9 (7), 741, 2021 | 13 | 2021 |
| Development of lentiviral vectors pseudotyped with influenza B hemagglutinins: Application in vaccine immunogenicity, mAb potency, and sero-surveillance studies F Ferrara, JMM Del Rosario, KAS Da Costa, R Kinsley, S Scott, ... Frontiers in Immunology 12, 661379, 2021 | 9 | 2021 |
| Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010 S Brinckmann, K Da Costa, MJ van Gils, D Hallengärd, K Klein, L Madeira, ... Journal of translational medicine 9, 1-12, 2011 | 8 | 2011 |
| Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell … D Horvath, N Temperton, M Mayora-Neto, K Da Costa, D Cantoni, ... Scientific Reports 13 (1), 4648, 2023 | 6 | 2023 |
| Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference B Wahren, P Biswas, M Borggren, A Coleman, K Da Costa, W De Haes, ... Journal of translational medicine 8, 1-11, 2010 | 6 | 2010 |
| Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) neuraminidase pseudotypes as tools for pandemic preparedness and improved influenza vaccine design KAS da Costa, JMM Del Rosario, M Ferrari, S Vishwanath, B Asbach, ... Vaccines 10 (9), 1520, 2022 | 3 | 2022 |
| AutoPlate: rapid dose-response curve analysis for biological assays P Palmer, JMM Del Rosario, KAS da Costa, GW Carnell, CQ Huang, ... Frontiers in Immunology 12, 681636, 2022 | 2 | 2022 |
| A pan-influenza monoclonal antibody neutralizes H5 strains and prophylactically protects through intranasal administration AL Beukenhorst, J Frallicciardi, KL Rice, MH Koldijk, JC Moreira de Mello, ... Scientific Reports 14 (1), 3818, 2024 | 1 | 2024 |
| Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1 A Alrubayyi, E Touizer, D Hameiri-Bowen, B Charlton, E Gea-Mallorquí, ... Scientific Reports 13 (1), 18994, 2023 | 1 | 2023 |
| HIV/HBV co-infection remodels the immune landscape and Natural Killer cell ADCC functional responses B Sun, KAS da Costa, A Alrubayyi, J Kokici, N Fisher-Pearson, N Hussain, ... Hepatology, 10.1097, 2024 | | 2024 |
| Serological evidence of virus infection in Eidolon helvum fruit bats: implications for bushmeat consumption in Nigeria D Cantoni, M Mayora-Neto, M Derveni, K Da Costa, J Del Rosario, ... Frontiers in Public Health 11, 1283113, 2023 | | 2023 |
| Pseudotyped Viruses for Influenza JMM Del Rosario, KAS da Costa, NJ Temperton Pseudotyped Viruses, 153-173, 2023 | | 2023 |
| Diego Cantoni 3, Reinhold Horlacher 4, Armin Günther 4, Alexander Brosig 4, Jenny Morath 4, Barbara Jakobs 4, Marcus Groettrup, Heinz Hoschuetzky 5, Jacques Rohayem 6 & Jan ter … D Horvath, N Temperton, M Mayora‑Neto, K Da Costa Scientific Reports 13, 4648, 2023 | | 2023 |
| Serological evidence of high pathogenicity virus infection in Eidolon helvum fruit bats in Nigeria D Cantoni, M Mayora Neto, B Auld, K Da Costa, J Del Rosario, VO Ameh, ... bioRxiv, 2023.06. 14.544916, 2023 | | 2023 |
| Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell … JT Meulen, D Horvath, N Temperton, MM Neto, KD Costa, D Cantoni, ... | | 2022 |
| Influenza A (N1-N9) and Influenza B (B/Victoria and B/Yamagata) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine Design. Vaccines … KAS da Costa, JMM Del Rosario, M Ferrari, S Vishwanath, B Asbach, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| Influenza A (N1-N9) and Influenza B (B/Vic and B/Yam) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine design KAS da Costa, JMM Del Rosario, M Ferrari, S Vishwanath, B Asbach, ... bioRxiv, 2021.09. 19.460966, 2021 | | 2021 |
| Establishment of pan-Influenza A (H1-H18) and pan-Influenza B (pre-split, Vic/Yam) Pseudotype Libraries for efficient vaccine antigen selection JMM Del Rosario, KAS da Costa, B Asbach, F Ferrara, M Ferrari, ... bioRxiv, 2021.05. 20.444964, 2021 | | 2021 |
